Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) studyMaud Lemoine, Mark Thursz, Louise Sarr et al.|The Lancet Global Health|2016Cited by 182
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in AfricaYusuke Shimakawa, Maud Lemoine, Muriel Vray et al.|Journal of Hepatology|2018Cited by 71
Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in AfricaYusuke Shimakawa, Maud Lemoine, Damien Cohen et al.|Clinical Infectious Diseases|2019Cited by 42
Implementation of an in‐house quantitative real‐time polymerase chain reaction method for Hepatitis B virus quantification in West African countriesS. Monty Ghosh, Isabelle Chemin, Souleymane Mboup et al.|Journal of Viral Hepatitis|2016Cited by 19